Both in R&D — Physical & Biological Sciences
bioAffinity Technologies vs OmniAb
Over the past year BIAF returned −90.8% and OABI returned +248.0%; their daily moves had a correlation of -0.02.
BIAF −90.8% OABI +248.0%Growth of $1, one year, split-adjusted
| Metric | BIAF | OABI |
|---|---|---|
| Price | $3.19 | $5.15 |
| Market cap | $1.9M | $751.2M |
| Today | +6.69% | +1.18% |
| 1 month | −48.5% | +4.7% |
| 6 months | −89.5% | +267.9% |
| Year to date | −82.0% | +178.4% |
| 1 year | −91.3% | +232.3% |
| Revenue growth (YoY) | +19.0% | +78.3% |
| Gross margin | 100.0% | 92.3% |
| Net margin | −222.8% | −393.9% |
| P/E (TTM) | — | — |
| Price / sales | 0.3× | 18.7× |
| Net cash | $1.8M | $64.2M |
| Dividend yield | — | — |
| Volatility (60d) | 825.9% | 71.6% |
| Short % of float | 11.4% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).